Rosemary Chester

1.7k citations
11 papers · 851 indexed · 1 hit paper · h-index 6
Topics
Palliative Care and End-of-Life Issues (4 papers)Breast Cancer Treatment Studies (2 papers)Patient Safety and Medication Errors (2 papers)
Partner nations
United KingdomAustralia

In The Last Decade

Rosemary Chester

11 papers receiving 812 citations

Hit Papers

ZD6474 inhibits vascular endothelial growth factor signal...20022026201020182002200400600

Peers

Rosemary Chester
Comparison fields: 5 of 95
  • Molecular Biology 385
  • Oncology 366
  • Pulmonary and Respiratory Medicine 267
  • Cancer Research 155
  • Endocrinology, Diabetes and Metabolism 104
Replace Babak Yazdani‐Biuki with:
Babak Yazdani‐Biuki Austria
Ermelinda De Maio Italy
Takehiro Sando Japan
Jing He United States
Raimondo Di Liello Italy
Eijiro Nakamura Japan
Vibeke Krüse Belgium
Magdolna Dank Hungary
Nazan Günel Türkiye
Laura A. Pike United States
Rosemary Chester relative to Babak Yazdani‐Biuki Austria Babak Yazdani‐Biuki's profile →
Citations per field
00.5×2.5×
Babak Yazdani‐Biuki · 1×
Citations per year

Countries citing papers authored by Rosemary Chester

Since Specialization
Citations

This map shows the geographic impact of Rosemary Chester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosemary Chester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosemary Chester more than expected).

Fields of papers citing papers by Rosemary Chester

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosemary Chester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosemary Chester. The network helps show where Rosemary Chester may publish in the future.

Co-authorship network of co-authors of Rosemary Chester

This figure shows the co-authorship network connecting the top 25 collaborators of Rosemary Chester. A scholar is included among the top collaborators of Rosemary Chester based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosemary Chester. Rosemary Chester is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 3
2 4
3 9
4 1
5 7
6 1
7 2
8 10
9 6
10
ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration.breakdown →
702
11 106

About Rosemary Chester

Rosemary Chester is a scholar working on Radiological and Ultrasound Technology, Emergency Medical Services and Geriatrics and Gerontology, having authored 11 papers that have together received 851 indexed citations. Recurring topics across this work include Palliative Care and End-of-Life Issues (4 papers), Breast Cancer Treatment Studies (2 papers) and Patient Safety and Medication Errors (2 papers). The work is most often cited by research in Oncology (366 citations), Cancer Research (155 citations) and Pulmonary and Respiratory Medicine (267 citations). Rosemary Chester has collaborated with scholars based in United Kingdom and Australia. Frequent co-authors include Brenda J Curry, Helen Musgrove, Michael Dukes, P.F. Wadsworth, Donald Ogilvie, Stephen R. Wedge, Graham H.P. Richmond, Jon Curwen, Andrew P. Thomas and Alison Bigley. Their work appears in journals such as Nature, Palliative Medicine and European Journal of Surgical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026